All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit the Lymphoma Coalition.
The Lymphoma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lymphoma Hub cannot guarantee the accuracy of translated content. The Lymphoma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The Lymphoma Hub is an independent medical education platform, sponsored by Roche, AbbVie, BeOne, Miltenyi Biomedicine, Thermo Fisher, Nurix Therapeutics and Caribou Biosciences and supported through independent educational grants from Incyte, Bristol Myers Squibb, Pfizer and Takeda Pharmaceuticals U.S.A., Inc. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account to access:
Bookmark & personalize site content
Receive alerts for new content in your areas of interest
View lymphoma & CLL content recommended for you
Grzegorz NowakowskiThe 9th of August 2018 saw the first case study from the Mayo Clinic featured on the Lymphoma Hub. This is the result of the exciting, new partnership between the Mayo Clinic and the Lymphoma Hub.
At the heart of this collaboration is Greg Nowakowski; lymphoma expert at the Mayo Clinic in Rochester and also a member of the Lymphoma Hub Scientific Advisory Board .
Every 2 weeks, a Multidisciplinary team at the Mayo Clinic (eTumor Board) meet to discuss four clinical cases on lymphoma. These meetings are video recorded and the Mayo Clinic will select appropriate, informational and diverse cases to be posted to the Lymphoma Hub.
Alongside our regular news articles, these real-world clinical case studies will be an incredibly valuable feature for our community hematologists. Cases will be presented with all supporting clinical information (clinical symptoms, imagery, laboratory findings, previous treatment etc.,) presentation of pathological findings supporting diagnosis (including pathology images) and discussion surrounding the clinical decision making process.
The Lymphoma Hub would like to thank the Mayo Clinic and Greg Nowakowski for sharing their expertise and the invaluable contribution of all the members of the eTumor Board. We look forward to the sharing of information for the good of continuing medical education.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
This content is accurate as of the date of publication and is not updated retrospectively. Please refer to the latest available evidence, guidelines, and relevant regulatory information when making clinical decisions.
Your opinion matters
When selecting the next therapy for patients with R/R MCL after BTKi progression, what is your most important consideration?